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ABST RACT
Colorectal cancer is a common form of cancer nowadays. There are
many risk factors in the pathogenesis of colorectal cancer. The malignant
proliferation is caused by one or more genetic mutations, which activate
oncogenes and deactivate tumor suppressor genes. Some factors cannot
be changed, such as a person's age or family history. An essential aspect
in the pathogenesis of colorectal cancer is the choice of lifestyles, such
as a high-fat diet, smoking, and excess alcohol. Carcinogens can be
either natural or chemical. The mechanisms by which carcinogens
initiate tumor formation are genetic or non-genotoxic. The most
common form of colorectal cancer is found in people who ingest
chemicals that, once ingested, reach the large intestine, thus causing
malignant lesions. The Western diet and the metabolic syndrome are risk
factors for colorectal cancer, due to gut microbiota changes and lowgrade chronic inflammation. Among the most important diet carcinogens
are nitrosamines, hydrazines, organophosphates, acetaldehyde, and
heterocyclic amines. Screening programs, especially among people over
50 years of age, and with multiple risk factors are extremely important
in detecting colorectal cancers in the early stages and in improving the
long-term prognosis in such patients.

Introduction
Colorectal cancer is currently the third type of cancer
in terms of prevalence worldwide, with 1.93 million new
CRC cases diagnosed in 2020. Its prevalence is on a
continuously ascending trend, the statistics models
estimate around 3.2 million new cases in 2040 [1]. Despite
the benefits of global screening procedures that have led to
a significant decline of CRC epidemiologic rates in the last
decades, this type of cancer still remains a major cause of
mortality worldwide [2].
In Romania, colorectal cancer is the most common
gastrointestinal malignancy, representing the third leading
cause of cancer death after lung and breast cancer [3].
Epidemiological studies showed that colorectal cancer is
the second most common type of cancer in women and the
third most common type of cancer in men, generating an
increase in the number of operations and subsequent
complications such as anastomotic leaks [4,5].
Consequently, the colorectal cancer represents a significant
economic burden in the healthcare systems [6].
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Recently, the Covid-19 pandemic overburdened the
national healthcare systems, being considered the most
severe sanitary crisis since the Spanish flu which occurred
100 years ago [7]. National healthcare systems reported
significant delays and disruptions in the oncological
screening programs and ambulatory routine check-ups [810]. There are concerns regarding the negative effects,
resulting in more cases diagnosed as an emergency, in
advanced stages and significant loss of years in the lives of
these patients [8,11].
While some risk factors are related to the genetic
predisposition, age, family history, there is strong evidence
that the Western style diet, smoking, changes in gut
microbiota and metabolic syndrome may play a significant
role in carcinogenesis [12-14]. Most colorectal cancers
start with a polyp. Some types of polyps can develop into
cancer over several years, but not all types of polyps turn
into cancer. The malignant proliferation is caused by one
or more genetic mutations, which activate oncogenes and
deactivate tumor suppressor genes. The incidence of
synchronous colorectal cancers varies between 1.8% and
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12.4% from the total amount of colon cancers [15]. In some
cases, they are correlated with microsatellite instability
(MSI), either inherited, such as Lynch syndromes, or by de
novo mutations of the repair genes [16]. However, in many
cases, the co-existence of gastrointestinal tumors is due to
the chronic exposure to the same toxic agents along the
gastrointestinal tract.

Discussion
The Western diet and the risk for colorectal cancer
Epidemiological data show the link between colon
cancer and its distribution in certain geographical areas.
Currently, large bowel cancer has the highest incidence of
all human neoplastic diseases in the United States. It has an
equally high incidence in other Western countries, while
on the African continent, Central and West Latin America
and Japan, it has a low incidence. In both high-risk and
low-risk individuals, significantly different levels of
certain key bacterial enzymes in the flora are even more
important. There are significant differences in neutral
sterols and bile acids, with the high-risk population having
higher levels in their stools. Experimental studies revealed
that animals on a high-fat diet excrete more neutral sterols
and bile acids than control subjects. Bile acids exert a
promoting effect on colon carcinogenesis in animal
models, thus highlighting the possible role of bile acids in
the development of human cancer [17-20].
The Western diet, rich in highly processed meat, fat and
sugars is associated with changes in the gut microbiota,
metabolic syndrome and insulin resistance. The chronic
low-grade inflammation, involving multiple pathways,
along with NLRP3 inflammasome, are associated
with a favorable tumor microenvironment, tumor
microenvironments having a great impact on tumor
development and immunity, representing a key factor in
the response to therapy [21,22]. While obesity is a wellknown factor associated with an increased risk of
colorectal cancer, the current knowledge is still scarce
regarding the outcomes of obese patients who underwent
bariatric surgery. Bariatric surgery is associated with a
rapid improvement in insulin resistance, cholesterol level,
arterial hypertension, as well as a decrease in systemic
inflammation status [23]. However, some studies showed a
higher risk for colorectal cancer in obese people that
underwent bariatric surgery [24], while others experienced
a significantly decreased risk [25,26].
The association between type II diabetes mellitus and
digestive neoplasms has been on an upward trend lately
due to common risk factors, as well as to mutually
potentiating effects on the evolution of the two conditions.
DM seems to be a risk factor for interval CRC and
advanced adenomatous lesions by accelerating the
colorectal epithelial proliferation rate [2,27].

Food chemicals and colorectal carcinogenesis
Carcinogenic factors play a special role in colorectal
cancer. Carcinogens can be natural, such as aflatoxin, or
they can be chemical, man-made. Carcinogens interact
with the DNA of a cell and induce genetic mutations. As a
result of these mutations, tumors appear, which have
the ability to metastasize and cause the dysfunction of
other tissues, culminating in organ failure and even
death [28-30].
The mechanisms by which carcinogens initiate tumor
formation are complex and may be classified as genetic
mechanisms - consisting in producing DNA changes and
triggering cell death, and non-genotoxic mechanisms - do
not involve the interaction with the DNA, but produce
immunosuppression and specific inflammation in the
tissues [31,32].
Aside from grilled foods which have a charred coating,
the foods that have been heat-treated contain preservatives
or have been contaminated with pesticides; they all have
the potential to cause colon cancer. The foods fried in the
same oil that has already been used more than twice have
been found to contain cancer-causing chemicals, due to the
deterioration in the oil quality. When such chemicals
accumulate in the body, it can increase the risk of cancer
occurring in the digestive system [33-35].
Carcinogenic chemical compounds
Hydrazines
Two of these naturally occurring compounds are
1,1-dimethylhydrazine, a tobacco ingredient, and
methylhydrazine, a chemical found in the wild edible
fungus Gyromitra esculenta.
Therefore, the human population is considerably
exposed to them. In addition, both compounds are
manufactured and used in missile fuel. The other three
chemicals,
1,2-dimethylhydrazine
dihydrochloride,
1-methyl-2-butylhydrazine
dihydrochloride
and
trimethylhydrazine hydrochloride, are only synthetically
produced and, apparently, are not found in large amounts
in the environment [36,37].
Nitrosamines
The consumption of foods treated with preservatives
almost constantly causes the majority of the population to
develop colon cancer. Food preservatives have an
extremely high content of nitrites. The combination of
nitrites and biogenic amines in the gut leads to the
formation of nitrosamines, with a definite carcinogenic
effect. Nitrosamines are a group of organic compounds that
have a general structural formula: R1N(–R2)–N=O, which
means that in their structure there is a nitrous group directly
linked to an amine functional group. Most nitrosamines
are carcinogenic, and are components of the cigarette
smoke. One such example is dimethylnitrosamine (CH3)2N–N=O [38].
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Nitrosamines are obtained by reacting nitrites with a
secondary amine, which may also be present in a protein
structure [39]. This happens when protein foods containing
nitrates or nitrites are cooked, such as meat products with
preservatives E 249 to E 252. These additives are nitrites
or nitrates, which, in turn, can be converted into nitrites.
Nitrosonium is the chemical species that will react with
the amine to produce protonated nitrosamine which is
then deprotonated by the solvent. The effect of high
temperatures can also promote the formation of
nitrosamines. By schematizing the whole reaction, the
following two phases can be described:
HO-N = O + H + → H 2 O + –N = O → N≡O + + H 2
O (1) [the formation of the nitrosonium ion]
R 2 NH + N≡O + → R 2 NN = O + H + (2) [nitrosamine
formation]
Nitrosamines are chemical compounds with low or
medium toxicity, but with an extremely high carcinogenic
potential. They can be formed not only from exogenous
sources (e.g., food), but also from endogenous sources
(e.g., in the stomach). The in vivo (endogenous) formation
occurs when exogenous or endogenous nitrate/ nitrite
levels stay above 1 mg%. The synthesis of nitrosamines in
the digestive tract takes place mainly in the stomach, where
the acidic environment is conducive to the nitrosation
process. At the intestinal level, even if the pH is close to
neutral or under certain alkaline conditions, the nitrosation
process can continue under the catalytic action of the
microbial flora [40].
Fertilizing the soil with nitrogen fertilizers can lead to
their accumulation in vegetables and later, after ingesting
them and accumulating over time, the carcinogenic effect
is very important.
Animal studies have shown that nitrosamines promote
the development of stomach and pharyngeal cancer and are
therefore suspected of causing it in humans [41]. Foods
with the highest nitrate content are smoked foods. Cereals,
alcoholic beverages and dairy products have an average
nitrite content. The content in spinach, radish, beets is
about ten times higher. Due to the infiltration of fertilizers
into the soil, groundwater also has a high nitrogen content.
Nitrosamine metabolism
Nitrosamines formed in the gastrointestinal tract are
absorbed into the blood at a level of 0.1 μg/ kg, depending
on the amount of nitrogen products ingested with food or
endogenously formed.
The metabolism of nitrosamines and their
transformation into active metabolites takes place through
enzymatic processes. Nitrosamines require metabolism for
their biological actions and the enzymes involved have
been considered to be somewhat atypical microsomal
mixed function oxidases [42]. Many nitrosamines are
metabolized by cytochromes P450, one of which
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(P450IIE1) has received much attention because of its role
in the metabolic activation of N-nitrosodimethylamine. In
addition, P450IIE1 is the most active P450 species known
in the metabolism of N-nitrosoethylmethylamine and Nnitrosopyrrolidine. P450IIB1 also catalyzes the alphaoxygenation of both the pentyl and methyl groups of Nnitrosopentylmethylamine, forming pentaldehyde and
formaldehyde at a rate ratio of 2:1, as well as oxygenation
at other carbons of the pentyl group. Many nitrosamines
are effectively activated in non-hepatic target tissues [43].
The appearance of malignant lesions caused by
nitrosamines could be due to the formation of free radicals,
as a result of their metabolism. For example, N-Methyl-Nnitrosamines are well-known carcinogens and DNAmethylating agents. DNA alkylation by this class of
compounds involves metabolic oxidative activation,
followed by decomposition to yield alkylating species. The
natural product dephostatin, isolated from Streptomyces, is
a tyrosine phosphatase inhibitor that contains the Nmethyl-N-nitrosamine functional group. It has been
suggested that the inhibition of tyrosine kinases resulted
from the nitroso group-transfer to a cysteine thiol of these
enzymes. If can serve as a substrate for appropriate
oxygenases, alkylation of DNA and other biomolecules by
this natural product is a possibility. In addition, the
semiquinone form may decompose with the loss of nitric
acid which, in the presence of molecular oxygen, can cause
DNA damage [44].
Nitrosamine toxicity
Bartzatt et al. demonstrated that the toxic effect of
nitrosamines can be established immediately in vivo,
leading to the alkylation of substrates [45]. Pei XF shows
that nitrosamines have had the effect of DNA synthesis in
a number of cultures. The carcinogenic potential of
nitrosamines has been tested in laboratory animals [46].
The results showed that only the esophagus is affected [45].
Acute nitrosamine toxicity and the carcinogenic
potential were determined on rat studies [47]. Thus, certain
nitrosamines have extremely high toxicity: for
imethylnitrosamine LD50 is 40 mg/ kg, and for
diethylnitrosamine LD50 is 200 mg/ kg. Other
nitrosamines are very toxic: methylnitrosamine (LD50 is
18 mg/ kg). the nitrosamines with the lowest toxicity are
ethyl-2-hydroxyethylnitrosamine (LD50 7,500 mg/ kg), di2-hydroxyethylnitrosamine (LD50 5,000 mg/ kg),
nitrosoprolidine (LD50 900 mg/ kg).
The higher the toxicity and concentration of
nitrosamines, the shorter the time of the onset of
malignancies. For the same type of nitrosamines, at low
concentrations, the appearance of tumors occurs after a
long period (1.5-2 years). However, the exact doses of
nitrosamines that cause carcinogenicity are not known.
Nitrosamines have a specific carcinogenic effect on each
organ. Thus, dimethylnitrosamine causes nasal sinus
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cancer, liver cancer and kidney cancer, and
diethylnitrosamine causes lung cancer. Dibutylnitrosamine
causes bladder cancer and ethylbutylnitrosamine leads to
gastric cancer [48-50].
No specific treatment exists for nitrosamine
intoxication. Supportive and symptomatic treatment
should be provided. Since nitrosamines and their
precursors are present in the food, exposure to nitrosamines
cannot be avoided.
Undergoing colon screening can help reduce the rate of
fatalities that occur from this form of cancer. Such
screening is especially advisable for high-risk groups, such
as people with a family history of cancer or those who
enjoy foods that may trigger the occurrence of cancer.
Other chemicals involved in colorectal cancer
The Organophosphate (OPEs) compound can be found
as a pesticide, in contaminated fruits and vegetables.
Surveys have found that out of the insecticides used in the
agricultural industry, the most common ones are those
containing organophosphate [51,52]. The studies about the
potential association between OPEs and gastrointestinal
cancer were limited. However, a recent study by Li et al.
found that the elderly male patients with gastric cancer
were more sensitive to the exposure of 2-ethylhexyl
diphenyl phosphate (EHDPP), while the triethyl phosphate
(TEP) exposure was more sensitive to the relatively young
gastrointestinal cancer patients [51].
Acetaldehyde is a chemical metabolite in ethanol
metabolism. This can eventually lead to the denaturation of
proteins and the destructions of cellular DNA. Moreover,
it can stimulate the production of numerous types of
cancer-causing genes [53].
Heterocyclic amines (HCAs) and polycyclic aromatic
hydrocarbons (PAHs) are chemicals found in grilled foods
that have become charred. Several studies have analyzed
the risk of colorectal cancer associated with the
consumption of red meat, the total meat intake and the
exposure to individual heterocyclic amines. Individual
measures of specific heterocyclic amines exposure
provided little additional value to the risk assessment when
compared to the measurement of the meat consumption,
thus suggesting that the exposure to other environmental or
dietary carcinogens such as nitrosamines may contribute to
colorectal cancer risks [54,55].
Acrylamide is a chemical that can be found in the food
that has been deeply fried or baked at high temperatures.
Some studies revealed that when this chemical is allowed
to build up in the body in time, it can increase the risk of
cancer in the digestive system [56-58].
Hogervorst et al. [57] found that dietary acrylamide
intake increases the risk of colorectal cancer with specific
mutations in KRAS and adenomatous polyposis coli (APC)
genes, 2 key genes in colorectal carcinogenesis. However,
currently, acrylamide is classified as a probable human

carcinogen. While in experimental studies on rats, the
incidence of colorectal tumors was higher after the
exposures of humans to large amounts of food containing
acrylamide, such as coffee, bread crust or fries, and it was
not associated with significantly increased carcinogenic
risks [58].
Diet protective factors
Several studies showed that dietary fibers may prevent
tumor formation at the colonic epithelium [59-61]. They
are further metabolized by the gut microbiome into short
chain fatty acids, with local anti-inflammatory and antiproliferative effects. Healthy microbiome associated with
high alimentary intake of dietary fibers and
phytomolecules could decrease cell proliferation by
regulating the epigenetic events which activate protooncogenes and the oncogenic pathways [60]. In a study by
Castello et al., the high adherence to the Mediterranean
diet, rich in fresh fruits and vegetables, olive oil, nuts and
fish could prevent colorectal cancer [62].

Highlights
✓ The diet in economically developed countries
comprises a multitude of carcinogens, either from
farming and conserving the aliments, or from
unhealthy means of preparation.
✓ Screening programs, especially in people over 50
years of age, and with multiple risk factors are
extremely important in detecting colorectal cancers in
the early stages.

Conclusions
The diet in economically developed countries contains
a variety of carcinogens, either from farming and
conserving the food, or from the unhealthy means of
preparation. On the other hand, a high number of calories
and a high fat diet may lead to the metabolic syndrome, and
a favorable environment for tumor development. Screening
programs, especially in people over 50 years of age, and
with multiple risk factors are extremely important in
detecting colorectal cancers in the early stages and in
improving the long-term prognosis in such patients.
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